Pyrimidine-2,4-Diamine Derivatives for Treatment of Cancer
申请人:THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING
公开号:US20160002175A1
公开(公告)日:2016-01-07
A compound of formula (I), or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.
The invention relates to a compound of formula (I) wherein R1-R3 are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament.